A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
Market Analysis and Insights: Global Biopharmaceutical Market
The global Biopharmaceutical market size is projected to reach US$ 230710 million by 2026, from US$ 214570 million in 2020, at a CAGR of 7.0%% during 2021-2026.
Global Biopharmaceutical Scope and Market Size
Biopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
North America
Europe
China
Japan
Southeast Asia
India
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
Market Analysis and Insights: Global Biopharmaceutical Market
The global Biopharmaceutical market size is projected to reach US$ 230710 million by 2026, from US$ 214570 million in 2020, at a CAGR of 7.0%% during 2021-2026.
Global Biopharmaceutical Scope and Market Size
Biopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Market segment by Type, the product can be split into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other
Market segment by Application, split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.